DC-SIGN Antibodies

Santa Cruz Biotechnology features a diverse variety of DC-SIGN monoclonal antibodies for advanced research in immunology and cell biology. DC-SIGN monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DC-SIGN, or Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin, plays a crucial role in the immune response by mediating the interaction between dendritic cells and pathogens, particularly in viral infections. DC-SIGN's ability to bind to various glycoproteins enables antigen presentation and immune response modulation, making it a significant target for therapeutic interventions and vaccine development. Understanding DC-SIGN function is essential for uncovering mechanisms of immune evasion by pathogens and developing strategies to enhance immune responses. Research into DC-SIGN continues to reveal new insights about its role in immune system regulation and pathogen recognition. DC-SIGN investigation has opened new avenues for understanding cellular immunity and host-pathogen interactions. Santa Cruz Biotechnology monoclonal antibodies for DC-SIGN research support scientists worldwide in advancing our understanding of immune system function and disease mechanisms.